Mobious Genomics Allowed Milestone US Sequencing Patents


Exeter, England. Mobious Genomics Ltd., the UK based bionanotechnology company, announced that it has received formal notice of allowance from the United States Patent Office for broad technology defining patents covering real-time polynucleotide sequencing. The patents outline the application of cellular replication systems to achieve commercially viable ultra high speed sequencing technology.

Relating to methods and devices for real-time monitoring of cellular replication processes in order to achieve ultra high throughput Genomic analysis as well as robust "regenerative" capabilities, the patents cover core elements of Mobious's platform technology. The patents are held my Mobious's patent holding company, Medical Biosystems Ltd.

Other news from the department research and development

Most read news

More news from our other portals

Recognise, understand, heal: The World of Diagnostics